Eiger BioPharmaceuticals Inc.

(EIGR) Trade

By |

Profile

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.

Contact Information

Website: www.eigerbio.com
Email: info@eigerbio.com
Main Phone: +1 650 272-6138
Address: 350 Cambridge Avenue
Address 2: Suite 350
State: CA
City / Town: Palo Alto
Country: USA
Postal Code: 94306

Issuer Information

Exchange: NSD
CEO: David Cory
Employees: 18
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 14.35 $ -0.2 (-1.37%)
Last Price 14.35 Change $ -0.2 Change % -1.37 Tick N/A
Bid 14.30 Bid Size 200.00 Ask 14.40 Ask Size 500.00
Open 14.40 High 14.58 Low 14.24 Prev Close 14.55
Last Trade Volume 62,956 52 Wk Hi 18.00 52 Wk Low 6.35
Market Cap 151.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 10,540,121.00 EPS (TTM) -4.36 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 3
Number of Buys 1 2
Number of Sells 1 1
Net Activity 0 15000
Last 10 Buys Shares
Jeffrey Glenn 1,000
Jeffrey Glenn 1,000
Jeffrey Glenn 1,000
David Cory 1,000
James P. Shaffer 1,000
James H. Welch 1,000
James H. Welch 1,000
James P. Shaffer 1,000
James P. Shaffer 1,000
James P. Shaffer 1,000
Last 10 Sell Shares
Joanne Quan 1,000
Krisztina M. Zsebo 1,000
Krisztina M. Zsebo 1,000
Rebecque J. Laba 1,000
Rebecque J. Laba 1,000
Ryan K. Takeya 1,000
Krisztina M. Zsebo 1,000
Krisztina M. Zsebo 1,000
Rebecque J. Laba 1,000
Rebecque J. Laba 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 53 53 53 53
Low Target Price Estimate 23 23 20 23
Mean Target Price Estimate 30.57 30.57 30.71 30.57
Standard Deviation 11.33 11.33 11.46 11.33
Date of Most Recent Estimate 05/31/18 05/31/18 05/18/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1